Literature DB >> 22977635

Association study between polymorphisms of CD28, CTLA4 and ICOS and non-segmental vitiligo in a Korean population.

Min Kyung Shin1, So Hee Im, Hae Jeong Park, Su Kang Kim, Sung Vin Yim, Joo-Ho Chung, Mu-Hyoung Lee.   

Abstract

CD28 molecule (CD28), cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and inducible T-cell co-stimulator (ICOS) are important regulators of the immune system. Vitiligo, a common autoimmune skin disorder, is characterized by a loss of melanocytes that results in cutaneous white patches. The aim of the present study was to determine whether or not polymorphisms of the CD28, CTLA4 and ICOS genes are associated with non-segmental vitiligo in a Korean population. To determine the relationships between CD28, CTLA4 and ICOS genes and vitiligo, four single nucleotide polymorphisms (SNPs) associated with the CD28 gene [rs1879877 (promoter, -1198), rs3181097 (promoter, -1059), rs2140148 (intron 1) and rs3116494 (intron 2)], two SNPs associated with the CTLA4 gene [rs231777 (intron 1) and rs231779 (intron 1)] and five SNPs associated with the ICOS gene [rs4270326 (intron 3), rs11571314 (intron 3), rs10183087 (3' untranslated region; UTR), rs4404254 (3'UTR) and rs1559931 (3'UTR)] were selected. Two hundred and thirty-one patients with non-segmental vitiligo (NSV) and 405 healthy controls were enrolled. Genotyping was performed using the restriction fragment length polymorphism technique and direct sequencing. SNPStats, Haploview 4.2 and SPSS 18.0 were used to conduct the analyses. Significant differences were noted between CTLA4 (p<0.05) and NSV, but not CD28 and ICOS (p>0.05). However, these associations disappeared after Bonferroni correction. The CD28, CTLA4 and ICOS genes may not be associated with NSV.

Entities:  

Year:  2011        PMID: 22977635      PMCID: PMC3440817          DOI: 10.3892/etm.2011.326

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  20 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

Review 2.  CD28/B7 system of T cell costimulation.

Authors:  D J Lenschow; T L Walunas; J A Bluestone
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

3.  Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies.

Authors:  Annalisa Brozzetti; Stefania Marzotti; Cristina Tortoioli; Vittorio Bini; Roberta Giordano; Francesco Dotta; Corrado Betterle; Annamaria De Bellis; Giorgio Arnaldi; Vincenzo Toscano; Emanuela Arvat; Antonio Bellastella; Franco Mantero; Alberto Falorni
Journal:  Eur J Endocrinol       Date:  2009-11-02       Impact factor: 6.664

4.  Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34.

Authors:  M Lafage-Pochitaloff; R Costello; D Couez; J Simonetti; P Mannoni; C Mawas; D Olive
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

5.  Matrix Metallopeptidase 2 Gene Polymorphism is Associated with Obesity in Korean Population.

Authors:  Dong Hee Han; Su Kang Kim; Sungwook Kang; Bong-Keun Choe; Keon Sik Kim; Joo-Ho Chung
Journal:  Korean J Physiol Pharmacol       Date:  2008-06-30       Impact factor: 2.016

6.  CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.

Authors:  Anne Blomhoff; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Eystein S Husebye; Hanne E Akselsen; Benedicte A Lie; Dag E Undlien
Journal:  Pigment Cell Res       Date:  2005-02

7.  CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data.

Authors:  Stanca A Birlea; Greggory S Laberge; Lucia M Procopciuc; Pamela R Fain; Richard A Spritz
Journal:  Pigment Cell Melanoma Res       Date:  2009-01-17       Impact factor: 4.693

8.  CTLA-4 A49G gene polymorphism is not associated with vitiligo in South Indian population.

Authors:  Farha Deeba; Rabbani Syed; Jariya Quareen; M A Waheed; Kaiser Jamil; Hanmanth Rao
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

9.  Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff.

Authors:  Raymond E Boissy; Richard A Spritz
Journal:  Exp Dermatol       Date:  2009-03-06       Impact factor: 3.960

10.  Association between IL4 (-590), ACE (I)/(D), CCR5 (Delta32), CTLA4 (+49) and IL1-RN (VNTR in intron 2) gene polymorphisms and vitiligo.

Authors:  Sacide Pehlivan; Ferda Ozkinay; Sibel Alper; Huseyin Onay; Eda Yuksel; Mustafa Pehlivan; Cihangir Ozkinay
Journal:  Eur J Dermatol       Date:  2009-01-07       Impact factor: 3.328

View more
  2 in total

1.  The CTLA-4 +49 A/G, CT60 A/G and PTPN22 1858 C/T polymorphisms and susceptibility to vitiligo: a meta-analysis.

Authors:  Gwan Gyu Song; Jae-Hoon Kim; Young Ho Lee
Journal:  Mol Biol Rep       Date:  2012-12-24       Impact factor: 2.316

Review 2.  Modern vitiligo genetics sheds new light on an ancient disease.

Authors:  Richard A Spritz
Journal:  J Dermatol       Date:  2013-05       Impact factor: 4.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.